Agenus
AGEN
#8970
Rank
NZ$0.23 B
Marketcap
NZ$6.80
Share price
-3.20%
Change (1 day)
10.95%
Change (1 year)

Agenus (AGEN) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$0.40 Billion

According to Agenus 's latest financial reports the company's total assets are NZ$0.40 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Agenus - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.40 B-19.17%
2023-12-31NZ$0.49 B-23.79%
2022-12-31NZ$0.65 B-4.52%
2021-12-31NZ$0.68 B129.46%
2020-12-31NZ$0.29 B28.9%
2019-12-31NZ$0.23 B13.42%
2018-12-31NZ$0.20 B4.35%
2017-12-31NZ$0.19 B-14.01%
2016-12-31NZ$0.22 B-35.96%
2015-12-31NZ$0.35 B272.08%
2014-12-31NZ$95.11 M124.38%
2013-12-31NZ$42.39 M19.87%
2012-12-31NZ$35.36 M39.35%
2011-12-31NZ$25.37 M-36.65%
2010-12-31NZ$40.06 M-36.57%
2009-12-31NZ$63.15 M-35.5%
2008-12-31NZ$97.91 M68.41%
2007-12-31NZ$58.14 M-43.85%
2006-12-31NZ$0.10 B-32.04%
2005-12-31NZ$0.15 B-18.28%
2004-12-31NZ$0.18 B-13.47%
2003-12-31NZ$0.21 B26.63%
2002-12-31NZ$0.17 B-24.46%
2001-12-31NZ$0.22 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Merck
MRK
NZ$224.24 B 55,287.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$142.73 B 35,155.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$333.76 B 82,338.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$1.12 B 177.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$167.71 B 41,324.85%๐Ÿ‡บ๐Ÿ‡ธ USA